Austrianova
Singapore, SG · 2 known investors
Austrianova develops cell encapsulation technologies, including Cell-in-a-Box for micro-encapsulating living cells for immuno-protection in patients and Bac-in-a-Box for protecting probiotic bacteria and yeast. It also provides cell biology services such as stem cell manufacturing, cell line development, and GMP cell banking for biotech and therapeutic applications.